OXCT1, a key rate-limiting enzyme in ketone body metabolism, is generally associated with poor prognosis when highly expressed in certain cancers, such as liver cancer16 and pancreatic cancer.17 The gene discussed is OXCT1; the disease is familial pancreatic carcinoma.